Position in ZTS
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$2,515
-$1,622 QoQ
Shares Held
35
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,325
of 1,408 holders
Holding Since
Jun 2020
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Elevated Capital Advisors, LLC holds $5,043 across 4 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (49.9% of the industry book) .
All Filings in ZTS
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,515 | 35 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $4,137 | 35 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $7,549 | 60 | Shares | Sole | 2026-01-27 | |
| 2022-09-30 | $1,150,433 | 7,758 | Shares | Sole | 2022-10-06 | |
| 2022-03-31 | $1,503,250 | 7,971 | Shares | Sole | 2022-04-20 | |
| 2021-09-30 | $1,557,391 | 8,022 | Shares | Sole | 2021-10-07 | |
| 2021-03-31 | $1,116,218 | 7,088 | Shares | Sole | 2021-04-21 | |
| 2020-12-31 | $1,079,887 | 6,525 | Shares | Sole | 2021-02-25 | |
| 2020-09-30 | $1,002,638 | 6,063 | Shares | Sole | 2020-11-27 | |
| 2020-06-30 | $971,613 | 7,090 | Shares | Sole | 2020-09-11 | |
| No filing history on record for this holder in this stock. | ||||||